NCT00655655 2024-08-21
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Mayo Clinic
Phase 1 Completed
Clinical Trials
9 trialsNCT00358163 2022-04-29
Trial of PTK787/ZK 222584 Plus Paclitaxel
Dana-Farber Cancer Institute
Phase 1 Terminated
NCT00390000 2019-04-08
Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors
Mayo Clinic
Phase 1 Completed
NCT00268918 2018-07-27
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
Dana-Farber Cancer Institute
Phase 1 Completed
NCT00303732 2016-03-03
PTK/RAD
Duke University
Phase 1 Completed
NCT00387933 2015-10-14
Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
Duke University
Phase 1 Completed
NCT00731861 2014-09-11
Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors
Indiana University
Phase 1 Completed
NCT00385853 2013-10-21
PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
Massachusetts General Hospital
Phase 1 Completed
NCT00611793 2009-01-23
PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies
SCRI Development Innovations, LLC
Phase 1 Completed